Antiretroviral use during pregnancy for treatment or prophylaxis

By Sturt Amy S   Read Jennifer S  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1875-1885

Informa Healthcare

Access to resources Recommend Favorite

Post-Exposure Influenza Prophylaxis with Oseltamivir: Cost Effectiveness and Cost Utility in Families in the UK

By Sander Beate  

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 373-386

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Primary Prophylaxis versus Treatment On-Demand for Individuals with Severe Haemophilia

By Miners A.H.  

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 759-774

Adis International

Access to resources Recommend Favorite

Extended Dalteparin Prophylaxis for Venous Thromboembolic Events: Cost-Utility Analysis in Patients Undergoing Major Orthopedic Surgery

By Dranitsaris George  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 45-58

Adis International

Access to resources Recommend Favorite

Flavonoids in the therapy and prophylaxis of flu: a patent review

By Costa Sônia S   Couceiro José Nelson S S   Silva Isabel Cristina V   Malvar David do C   Coutinho Marcela A S   Camargo Luiza Maria M   Muzitano Michelle F   Vanderlinde Frederico A  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1111-1121

Informa Healthcare

Access to resources Recommend Favorite